Publications by authors named "C Deschasse"
Purpose: To report visual and anatomical outcomes and determine predictors of good visual acuity (VA) recovery after macula-off rhegmatogenous retinal detachment (RD).
Methods: Prospective multicentre study including 115 eyes from 115 patients successfully operated on for RD, with assessment of VA and spectral-domain optical coherence tomography (SD-OCT) macular images at 1, 3, 6 and 12 months after surgery.
Results: Over the follow-up period, VA significantly improved from median [IQR] 62 [46; 72] ETDRS letters at 1 month to 75 [67; 80] ETDRS letters at 12 months (p < 0.
Purpose: To investigate the prevalence of vitreomacular interface abnormalities (VMIAs) in a French elderly glaucomatous population.
Methods: Using a population-based study, the MONTRACHET (Maculopathy Optic Nerve nuTRition neurovAsCular and HEarT diseases) study conducted in Dijon from 2009 to 2013 in individuals older than 75 years, the prevalence of VMIAs was estimated on glaucoma patients.
Results: A total of 1130 participants (2225 eyes) were included in the study.
Background: Behçet's disease (BD) is a recurrent multisystemic disease responsible for occlusive vasculitis with arterial, venous and capillary involvement. The aim of this study was to determine the frequency and the features associated with the use of biotherapy in the management of patients followed in our department for BD.
Methods: This is a retrospective study of patients medical records followed for BD in a department of internal medicine from January 2005 to August 2018.
: To discuss the use of tocilizumab in mild to severe Graves' ophthalmopathy as corticosteroid-adjunctive therapy. : Retrospective case reports.: Three patients with corticosteroid-resistant or advanced diplopia-associated Graves' ophthalmopathy were subsequently treated with monthly intravenous tocilizumab at a dose of 8 mg/kg.
View Article and Find Full Text PDFArticle Synopsis
- This study assessed the safety and effectiveness of repeated dexamethasone implants over three years in patients with macular edema due to either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).
- A total of 66 patients participated, with some receiving only dexamethasone implants while others first received implants and then switched to anti-VEGF treatments.
- Key findings included a significant improvement in best-corrected visual acuity (BCVA) and reductions in central retinal thickness (CRT) after treatment, although adverse events like cataract extraction and elevated intraocular pressure were common.